Quest Diagnostics Inc (DGX) |
|
|
|
Quest Diagnostics Inc Income Statement Annual
DGX
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
INCOME STATEMENT (Annual GAAP In millions $) |
(Dec 31 2019) 2019 |
(Dec 31 2018) 2018 |
(Dec 31 2017) 2017 |
(Dec 31 2016) 2016 |
(Dec 31 2015) 2015 |
Revenue From Contract With Customer Excluding Assessed Tax |
7,726.00 |
- |
- |
- |
- |
Total Revenue |
7,726.00 |
7,531.00 |
7,709.00 |
7,515.00 |
7,493.00 |
Cost of Revenue |
5,037.00 |
4,926.00 |
4,719.00 |
4,616.00 |
4,657.00 |
Gross
Profit |
2,689.00 |
2,605.00 |
2,990.00 |
2,899.00 |
2,836.00 |
Selling, Administration, Marketing |
1,457.00 |
1,424.00 |
1,750.00 |
1,681.00 |
1,679.00 |
Gain (Loss) on Disposition of Business |
- |
4.00 |
- |
-118.00 |
-334.00 |
Depriciation & Amortization |
96.00 |
90.00 |
74.00 |
72.00 |
81.00 |
Research & development |
- |
- |
- |
- |
- |
Restructuring charges |
- |
- |
- |
- |
- |
Other exp. /-income |
-95.00 |
-14.00 |
1.00 |
-13.00 |
11.00 |
Special charge |
- |
- |
- |
- |
- |
Total operating costs including COS |
6,495.00 |
6,430.00 |
6,544.00 |
6,238.00 |
6,094.00 |
Operating income/-loss
|
1,231.00 |
1,101.00 |
1,165.00 |
1,277.00 |
1,399.00 |
Other Deductions / - Income |
Interest expense |
175.00 |
167.00 |
151.00 |
143.00 |
153.00 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
175.00 |
167.00 |
-151.00 |
143.00 |
-153.00 |
Loss (Income) from Equity Method Investments |
- |
44.00 |
-35.00 |
39.00 |
23.00 |
Minority Interests Income/ -Loss |
- |
- |
- |
- |
- |
Sale of assets |
- |
- |
- |
- |
- |
Financing Loss/ -Income |
- |
- |
- |
- |
- |
Other loss/ -income |
-20.00 |
-36.00 |
19.00 |
9.00 |
120.00 |
Total costs & expenses |
6,650.00 |
6,605.00 |
6,679.00 |
6,429.00 |
6,390.00 |
Income /-loss before income taxes |
1,076.00 |
926.00 |
1,030.00 |
1,086.00 |
1,103.00 |
Income taxes expenses/-benefit |
247.00 |
182.00 |
241.00 |
429.00 |
373.00 |
Income after income taxes |
886.00 |
788.00 |
824.00 |
696.00 |
753.00 |
Net income/-loss
of other equity |
57.00 |
44.00 |
35.00 |
39.00 |
23.00 |
Income/-loss
from cont. Ops. |
886.00 |
788.00 |
824.00 |
696.00 |
753.00 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
20.00 |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
906.00 |
788.00 |
824.00 |
696.00 |
753.00 |
Noncontrolling interests |
48.00 |
52.00 |
52.00 |
51.00 |
44.00 |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
858.00 |
736.00 |
772.00 |
645.00 |
709.00 |
EBIT |
1,251.00 |
1,093.00 |
879.00 |
1,229.00 |
0.00 |
EBITD |
1,580.00 |
1,402.00 |
1,149.00 |
1,478.00 |
0.00 |
EBITDA |
1,580.00 |
1,402.00 |
1,149.00 |
1,478.00 |
0.00 |
Per
Share (GAAP Annual, in $) |
(Dec 31 2019) 2019 |
(Dec 31 2018) 2018 |
(Dec 31 2017) 2017 |
(Dec 31 2016) 2016 |
(Dec 31 2015) 2015 |
Basic EPS (excl. extra
items) |
6.21 |
5.39 |
5.63 |
4.58 |
4.92 |
Extraordinary items |
0.15 |
0.00 |
0.00 |
0.00 |
0.00 |
Basic Net EPS |
6.36 |
5.39 |
5.63 |
4.58 |
4.92 |
Basic shares outstanding (Mill.
of Units) |
134.91 |
136.55 |
137.12 |
140.83 |
144.11 |
EPS other shares |
- |
- |
- |
- |
- |
Diluted Net EPS |
6.28 |
5.29 |
5.50 |
4.51 |
4.87 |
Diluted average shares (Mill.
of Units) |
136.62 |
139.13 |
140.36 |
143.02 |
145.59 |
Dividend per share |
2.093 |
1.912 |
1.76 |
1.559 |
1.52 |
|
|